Cure Logo

Partnered Events

AML Summit



Deerfield Management and the Deerfield Foundation will honor the 2023-2024 recipients of the American Society of Hematology (ASH) Peter Steelman Scholar Award at the second annual Acute Myeloid Leukemia (AML) Summit on June 18, 2024. The AML Summit, which convenes industry experts, leaders, and partners across healthcare to further advance research on this cancer of the bone marrow and blood, will be held at Cure, the healthcare innovation campus and affiliate of Deerfield.

The AML Summit will recognize Emily Heikamp, M.D., Ph.D., M.Sc., and Sascha Haubner, M.D., as the 2023-2024 recipients of the ASH Peter Steelman Scholar Award for their academic achievements and contributions to AML research:


The AML Summit will showcase innovative clinical initiatives and cutting-edge research in AML and includes featured guest speakers:

  • Ross Levine, M.D., Leukemia Specialist & Physician-Scientist at Memorial Sloan Kettering Cancer Center; Chair of the AML Summit

  • Simone Riedel, Ph.D., Research Assistant Professor of Pediatrics (Oncology) at Perelman School of Medicine at the University of Pennsylvania

  • Emily Heikamp, M.D. Ph.D., M.Sc., Instructor in Pediatric Hematology – Oncology and Stem Cell Transplantation at Dana-Farber Cancer Institute

  • Sascha Haubner, M.D., Senior Research Scientist | CAR Therapy at Memorial Sloan Kettering Cancer Center

  • Scott Armstrong, M.D., Ph.D., President, Dana-Farber/Boston Children's Cancer and Blood Disorders Center; Chairman, Department of Pediatric Oncology at Dana-Farber Cancer Institute; Associate Chief, Division of Hematology/Oncology at Boston Children's Hospital; and David G. Nathan Professor of Pediatrics at Harvard Medical School

  • Manuel Aivado, M.D., Ph.D., CEO of Stelexis

  • Julian Adams, Ph.D., President and CEO of Stand Up To Cancer

  • Jeff Spear, LLP